<DOC>
	<DOCNO>NCT02289755</DOCNO>
	<brief_summary>The purpose study evaluate effect ALLN-177 reduce urinary oxalate excretion patient recur kidney stone enteric idiopathic hyperoxaluria .</brief_summary>
	<brief_title>Evaluating ALLN-177 Reducing Urinary Oxalate Excretion Calcium Oxalate Kidney Stone Formers With Hyperoxaluria</brief_title>
	<detailed_description>A multi-center , open-label , single arm study evaluate safety effect ALLN-177 reduce urinary oxalate excretion recurrent kidney stone former associate hyperoxaluria . The study design include screening period confirm eligibility , follow 3-day baseline period , 4-day open label treatment period ALLN-177 4-day follow period .</detailed_description>
	<mesh_term>Kidney Calculi</mesh_term>
	<mesh_term>Nephrolithiasis</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<criteria>Able provide inform consent Able comply study procedure History enteric idiopathic hyperoxaluria least one calcium oxalate kidney stone Hyperoxaluria &gt; 36mg oxalate/24hr May take drug prevention stone disease long change medication least 3 month Uric acid â‰¥1.5g/24hr Estimated glomerular filtration rate &lt; 60 mL/min Positive result drug urine screen Requires daily vitamin C ( define &gt; 10 day &gt; 300 mg/day ) Diagnosis hypercalcemia hypothyroidism Obstructive uropathy , chronic urosepsis , renal failure , renal tubular acidosis , primary hyperparathyroidism , primary hyperoxaluria , pure uric acid cystine stone , and/or medullary sponge kidney . Autoimmune disorder require high dose steroid immunosuppressant drug . Subjects pregnant . Women childbearing potential must negative pregnancy test prior enrollment must practice approve method birth control trial History cancer diagnosis except within past 5 year exclude dermal squamous and/or basal cell carcinoma cervical carcinoma situ . Taken investigational compound within 30 day prior first day study Treatment cholestyramine Average daily dietary intake &lt; 75 mg oxalate per day calculate diet recall</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Urine Oxalate</keyword>
	<keyword>Nephrolithiasis</keyword>
	<keyword>Kidney Stones</keyword>
	<keyword>Hyperoxaluria</keyword>
	<keyword>Enteric Hyperoxaluria</keyword>
	<keyword>Idiopathic Hyperoxaluria</keyword>
	<keyword>Urological Diseases</keyword>
	<keyword>Kidney Diseases</keyword>
</DOC>